MMP-9-IN-7 structure
|
Common Name | MMP-9-IN-7 | ||
|---|---|---|---|---|
| CAS Number | 333746-76-2 | Molecular Weight | 394.90 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C16H15ClN4O2S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MMP-9-IN-7MMP-9-IN-7 is a potent MMP9 inhibitor with an IC50 of 0.52 μM in proMMP9/MMP3 P126 activation assay. MMP-9-IN-7 is extracted from patent WO2012162468 (example 59), and can be used for MMP9/MMP13 mediated syndrome research[1]. |
| Name | WAY-299185 |
|---|---|
| Synonym | More Synonyms |
| Description | MMP-9-IN-7 is a potent MMP9 inhibitor with an IC50 of 0.52 μM in proMMP9/MMP3 P126 activation assay. MMP-9-IN-7 is extracted from patent WO2012162468 (example 59), and can be used for MMP9/MMP13 mediated syndrome research[1]. |
|---|---|
| Related Catalog | |
| Target |
MMP-9:0.52 μM (IC50) |
| References |
| Molecular Formula | C16H15ClN4O2S2 |
|---|---|
| Molecular Weight | 394.90 |
| Acetamide, N-[2-[(5-chloro-2-methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]- |